Effectiveness and Safety of Contemporary Drug-Eluting Stents in Patients With Diabetes Mellitus.

ABSTRACT:

Background

Diabetes mellitus (DM) is a well-known risk factor for adverse cardiovascular events in patients receiving percutaneous coronary intervention (PCI). Limited data are available on the relative performance of different types of contemporary drug-eluting stents (DES) for diabetic patients.

Objectives

The authors investigated the effectiveness and safety profiles of several contemporary DES in patients with DM in a "real-world" clinical setting.

Methods

Among 24,516 patients enrolled in a multicenter, prospective registry, 7,823 patients with DM were treated with 4 contemporary DES: 2,877 with a cobalt chromium everolimus-eluting stent (EES), 789 with a biodegradable polymer biolimus-eluting stent, 2,286 with a platinum chromium-EES, and 1,871 with a Resolute z

SUBMITTER: Yang Y 

PROVIDER: S-EPMC9627859 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature